查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1673039

幹細胞銀行市場：依來源類型、依服務類型、依應用、按地區

Stem Cell Banking Market, By Source Type, By Service Type, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 148 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球幹細胞銀行市場規模預計為 65 億美元，預計到 2032 年將達到 170 億美元，2025 年至 2032 年的複合年成長率為 14.7%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 65億美元
效能資料 2020-2024 預測期 2025-2032
預測期：2025 年至 2032 年複合年成長率 14.70％ 2032 年金額預測 170億美元
數字。 2025 年幹細胞銀行市場佔有率（%）（按地區分類）
幹細胞銀行市場-IMG1

幹細胞是未分化的生物細胞，可以在體內分化為特化細胞。如果捐贈者或其家人需要，將這些幹細胞儲存起來以便於保存和儲存以供將來的治療使用。人們對幹細胞療法治療癌症和血液疾病等慢性疾病的認知不斷提高，這推動了對幹細胞庫的需求。人們對女性健康的興趣日益濃厚以及社會對幹細胞研究的興趣日益增加預計將推動市場成長。然而，獲取和儲存幹細胞的高成本可能會阻礙市場的成長。預計不久的將來，科學與技術的進步將帶來幹細胞庫的進一步創新。

市場動態

全球幹細胞銀行市場的成長主要受到癌症和血液疾病等慢性和危及生命的疾病的增加的推動。幹細胞療法是此類疾病的潛在替代治療方法。增加公共和私人投資以鼓勵全球幹細胞研究活動也推動了市場成長。人們對女性生育能力保存等健康議題的興趣日益濃厚，幹細胞移植成功率也不斷提高，推動幹細胞庫的普及。然而，開採、加工、儲存和運輸的高成本可能會阻礙市場成長。政府和私人機構不斷加強的宣傳活動，推動新生兒臍帶血庫的建立，也為市場成長創造了新的機會。市場先驅者正在投資研發，以開發改進的幹細胞處理和儲存技術。

研究的主要特點

  • 本報告對全球幹細胞銀行市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
  • 它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 本報告根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球幹細胞銀行市場的主要企業。
  • 主要企業包括 Stem Cyte, Inc.、CRYO-CELL INTERNATIONAL, INC.、ViaCord、Cord Blood Registry、SmartCells, Inc.、LifeCell International Pvt。有限公司、Cryoviva BIoTech Pvt. Ltd.、Cryo Stemcell、Reliance Life Sciences、Transcell Biolife Pvt. Ltd.、Cordlife Group Limited、Covis Pharma 和 CSG Bio。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球幹細胞銀行市場迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過全球幹細胞庫市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 監管情景
  • 流行病學
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第 4 章 全球幹細胞銀行市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 2020 年至 2032 年按來源類型分類的全球幹細胞銀行市場（十億美元）

  • 介紹
  • 臍帶幹細胞
  • 臍帶血
  • 臍帶組織
  • 胎盤
  • 成體幹細胞
  • 胚胎幹細胞

6. 2020 年至 2032 年按服務類型分類的全球幹細胞銀行市場（十億美元）

  • 介紹
  • 收集和運輸
  • 過程
  • 分析
  • 貯存

7. 2020 年至 2032 年全球幹細胞銀行市場應用（單位：十億美元）

  • 介紹
  • 白血病
  • 糖尿病
  • 淋巴瘤
  • 腦性麻痹
  • 地中海型貧血
  • 其他

8. 2020 年至 2032 年全球幹細胞銀行市場（按地區分類）（單位：十億美元）

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 公司簡介
    • Stem Cyte, Inc.
    • CRYO-CELL INTERNATIONAL, INC.
    • ViaCord
    • Cord Blood Registry
    • SmartCells, Inc.
    • LifeCell International Pvt. Ltd.
    • Cryoviva BIoTech Pvt. Ltd.
    • Cryo Stemcell
    • Reliance Life Sciences
    • Transcell Biolife Pvt. Ltd.
    • Cordlife Group Limited
    • Covis Pharma
    • CSG Bio

第 10 章分析師建議

  • 興衰
  • 一致的機會地圖

第 11 章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1354

Global Stem Cell Banking Market is estimated to be valued at USD 6.50 Bn in 2025 and is expected to reach USD 17.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.50 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.70% 2032 Value Projection: USD 17.00 Bn
Figure. Stem Cell Banking Market Share (%), By Region 2025
Stem Cell Banking Market - IMG1

Stem cells are undifferentiated biological cells that are capable of differentiating into specialized cell types in the body. Banking these stem cells facilitates their storage and preservation for future therapeutic use, when required by the donor or related family members. Growing awareness about stem cell therapies for treating chronic conditions such as cancer and blood disorders has boosted demand for stem cell banking. Increasing focus on women's health and rising public interest in stem cell research are expected to drive the market growth. However, high costs associated with stem cell collection and storage procedures may hamper the market growth. Scientific and technological advancements are expected to drive more innovation in stem cell banking in the near future.

Market Dynamics:

Global stem cell banking market growth is primarily driven by rising prevalence of life-threatening chronic diseases like cancer and blood disorders. Stem cell therapies offer potential treatment alternatives for such conditions. Increasing public-private investments to encourage stem cell research activities around the world also drives the market growth. Growing women's health concerns regarding fertility preservation and rising success rates of stem cell transplants boosts adoption of stem cell banking. However, high costs of collection, processing, storage, and transportation procedures can hamper the market growth. Rising awareness campaigns by government and private agencies to promote cord blood banking at childbirth also presents new opportunities for market growth. Market players are investing in R&D to develop improved stem cell processing and storage technologies.

Key Features of the Study:

  • This report provides an in-depth analysis of the global stem cell banking market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global stem cell banking market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Stem Cyte, Inc., CRYO-CELL INTERNATIONAL, INC., ViaCord, Cord Blood Registry, SmartCells, Inc., LifeCell International Pvt. Ltd., Cryoviva Biotech Pvt. Ltd., Cryo Stemcell, Reliance Life Sciences, Transcell Biolife Pvt. Ltd., Cordlife Group Limited, Covis Pharma, CSG Bio.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global stem cell banking market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell banking market.

Detailed Segmentation-

  • By Source Type:
    • Umbilical Cord Stem Cell
    • Cord Blood
    • Cord Tissue
    • Placenta
    • Adult Stem Cell
    • Embryonic Stem Cell
  • By Service Type:
    • Collection and Transportation
    • Processing
    • Analysis
    • Storage
  • By Application:
    • Leukemia
    • Diabetes
    • Lymphoma
    • Cerebral Palsy
    • Thalassemia
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Stem Cyte, Inc.
    • CRYO-CELL INTERNATIONAL, INC.
    • ViaCord
    • Cord Blood Registry
    • SmartCells, Inc.
    • LifeCell International Pvt. Ltd.
    • Cryoviva Biotech Pvt. Ltd.
    • Cryo Stemcell
    • Reliance Life Sciences
    • Transcell Biolife Pvt. Ltd.
    • Cordlife Group Limited
    • Covis Pharma
    • CSG Bio

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Source Type
    • Market Snapshot, By Service Type
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Epidemiology
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Stem Cell Banking Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Stem Cell Banking Market, By Source Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Umbilical Cord Stem Cell
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cord Blood
  • Cord Tissue
  • Placenta
  • Adult Stem Cell
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Embryonic Stem Cell
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Stem Cell Banking Market, By Service Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Collection and Transportation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Processing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Analysis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Storage
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Stem Cell Banking Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Leukemia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diabetes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Lymphoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cerebral Palsy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Thalassemia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Stem Cell Banking Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Stem Cyte, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CRYO-CELL INTERNATIONAL, INC.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ViaCord
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cord Blood Registry
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SmartCells, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LifeCell International Pvt. Ltd.
    • Cryoviva Biotech Pvt. Ltd.
    • Cryo Stemcell
    • Reliance Life Sciences
    • Transcell Biolife Pvt. Ltd.
    • Cordlife Group Limited
    • Covis Pharma
    • CSG Bio

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact